News 9/16

Amgen’s Kyprolis and Janssen’s Darzalex combination approved by the US FDA for multiple myeloma

ipharmaservices

Aug 22, 2020

AZ received one more approval in Japan, received approval of Imfinzi for SCLC

ipharmaservices

Aug 22, 2020

Novartis Kesimpta approved for relapsing multiple sclerosis in the US

ipharmaservices

Aug 21, 2020

FDA says no to Gilead’s most anticipated product filgotinib

ipharmaservices

Aug 19, 2020

CORONAVIRUS RECOMMENDATIONS FROM VARIOUS HEALTH AGENCIES

ipharmaservices

Aug 18, 2020

Sanofi acquired Principia Biopharma to strengthen immunology and allergic portfolio

ipharmaservices

Aug 17, 2020

Genentech’s Enspryng approved for Neuromyelitis Optica Spectrum Disorder in the US

ipharmaservices

Aug 15, 2020

Gilead submitted NDA for Veklury to treat COVID-19 in the US

ipharmaservices

Aug 13, 2020

China’s National Medicinal Products Administration approved Gilead’s Truvada

ipharmaservices

Aug 12, 2020

FDA approved Genentech’s Evrysdi for Spinal Muscular Atrophy

ipharmaservices

Aug 8, 2020

NOVARTIS COSENTYX APPROVED IN EUROPE FOR PAEDIATRIC PSORIASIS

ipharmaservices

Aug 8, 2020

GSK’s first anti-BCMA therapy Blenrep was approved in the US

ipharmaservices

Aug 6, 2020

JULY 2020 CHMP POSITIVE OPINION

ipharmaservices

Jul 26, 2020

H1 2020 REVENUES OF PHARMACEUTICAL COMPANIES

ipharmaservices

Jul 26, 2020

Gilead’s CAR-T cell therapy approved for Relapsed or Refractory Mantle Cell Lymphoma

ipharmaservices

Jul 25, 2020

The US FDA approved Janssen’s psoriasis blockbuster for Psoriatic Arthritis

ipharmaservices

Jul 17, 2020

Eisai's Dayvigo was approved in Japan and Hong Kong for insomnia

ipharmaservices

Jul 9, 2020

European Commission approved Lynparza for metastatic pancreatic cancer

ipharmaservices

Jul 9, 2020

US FDA approved Rukobia (fostemsavir) for HIV patients who have limited treatment options

ipharmaservices

Jul 3, 2020

Gilead’s Veklury received conditional marketing authorization from the European Commission

ipharmaservices

Jul 3, 2020

iPharmaCenter

ipharmacenter Consulting services

Amgen’s Kyprolis and Janssen’s Darzalex combination approved by the US FDA for multiple myeloma

AZ received one more approval in Japan, received approval of Imfinzi for SCLC

Novartis Kesimpta approved for relapsing multiple sclerosis in the US

FDA says no to Gilead’s most anticipated product filgotinib

CORONAVIRUS RECOMMENDATIONS FROM VARIOUS HEALTH AGENCIES

Sanofi acquired Principia Biopharma to strengthen immunology and allergic portfolio

Genentech’s Enspryng approved for Neuromyelitis Optica Spectrum Disorder in the US

Gilead submitted NDA for Veklury to treat COVID-19 in the US

China’s National Medicinal Products Administration approved Gilead’s Truvada

FDA approved Genentech’s Evrysdi for Spinal Muscular Atrophy

NOVARTIS COSENTYX APPROVED IN EUROPE FOR PAEDIATRIC PSORIASIS

GSK’s first anti-BCMA therapy Blenrep was approved in the US

JULY 2020 CHMP POSITIVE OPINION

H1 2020 REVENUES OF PHARMACEUTICAL COMPANIES

Gilead’s CAR-T cell therapy approved for Relapsed or Refractory Mantle Cell Lymphoma

The US FDA approved Janssen’s psoriasis blockbuster for Psoriatic Arthritis

Eisai's Dayvigo was approved in Japan and Hong Kong for insomnia

European Commission approved Lynparza for metastatic pancreatic cancer

US FDA approved Rukobia (fostemsavir) for HIV patients who have limited treatment options

Gilead’s Veklury received conditional marketing authorization from the European Commission